BC Cancer - Victoria

2410 Lee Avenue
Victoria, BC, V8R 6V5

Clinical Trial Unit Manager
Philip Pollock
250-519-5597
philip.pollock@bccancer.bc.ca

Prostate

PROTRACT (Prostate Cancer Treatment Optimization via Analysis of Circulating Tumour DNA) Study: A Randomized Phase II Trial Comparing Biomarker Directed Therapy versus Clinician's Choice of Enzalutamide or Docetaxel in Patients with Advanced Prostate Cancer Post-Abiraterone

Cancer Type
Prostate
Phase II
Recruiting Dates
BC Cancer - Victoria
Open Recruiting Date
BC Cancer - Vancouver
Open Recruiting Date
BC Cancer - Surrey
Open Recruiting Date
BC Cancer - Kelowna (Sindi Ahluwalia Hawkins Centre)
View on ClinicalTrials.gov

PLATON: A Randomized Phase III Study of Local Ablative Therapy for Hormone Sensitive Oligometastatic Prostate Cancer 

Cancer Type
Prostate
Phase III
Recruiting Dates
BC Cancer - Victoria
Open Recruiting Date
View on ClinicalTrials.gov

A Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-KEYNOTE-641: A Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) 

Cancer Type
Prostate
Phase III
Recruiting Dates
BC Cancer - Victoria
Open Recruiting Date
View on ClinicalTrials.gov

AMPLITUDE: A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

Cancer Type
Prostate
Phase III
Recruiting Dates
BC Cancer - Vancouver
Open Recruiting Date
BC Cancer - Kelowna (Sindi Ahluwalia Hawkins Centre)
BC Cancer - Victoria
Open Recruiting Date
View on ClinicalTrials.gov
Back to top